Alsevalimab Antibody
Alsevalimab (FPA-150) is a humanized monoclonal antibody directed against the immune checkpoint protein B7-H4. It is utilized in oncology research to investigate its anti-tumor potential, with applications in both in vitro cellular assays and in vivo preclinical models for solid tumors.
Product Specifications
Product Name Alternative
FPA150, FPA-150, Anti-B7-H4 antibody
Target
Others
Clonality
Monoclonal
Conjugation
Unconjugated
Concentration
9.93 mg/mL
Purity
98.92% (May vary between batches)
Molecular Weight
144.78 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
